![Michael Mensinger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Mensinger
Corporate Officer/Principal bij
BETA BIONICS, INC.
Vermogen: 2 M $ op 31-05-2026
Profiel
Michael Robert Mensinger is currently Chief Product Officer at Beta Bionics, Inc., a position started in 2023.
Formerly, Mr. Mensinger was Chief Technology Officer at Companion Medical, Inc. from 2017 to 2023.
Prior to that, Mr. Mensinger was Director-Software Engineering at DexCom, Inc. from 2014 to 2017.
Mr. Mensinger completed undergraduate education at the University of Delaware.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BETA BIONICS, INC. 0,41% | 02-06-2026 | 184.415 ( 0,41% ) | 2 M $ | 31-05-2026 |
BETA BIONICS, INC. -.--% | 29-01-2025 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van Michael Mensinger
| Bedrijven | Functie | Begin |
|---|---|---|
| BETA BIONICS, INC. | Corporate Officer/Principal | 01-08-2023 |
Eerdere bekende functies van Michael Mensinger
| Bedrijven | Functie | Einde |
|---|---|---|
Companion Medical, Inc.
 Companion Medical, Inc. Medical SpecialtiesHealth Technology Manufactures insulin injector pens for diabetes management | Hoofd Techniek/Wetenschap/O&O | 01-08-2023 |
| DEXCOM, INC. | Corporate Officer/Principal | 01-04-2017 |
Opleiding van Michael Mensinger
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
42
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Companion Medical, Inc.
Companion Medical, Inc. Medical SpecialtiesHealth Technology Manufactures insulin injector pens for diabetes management | Health Technology |
DexCom, Inc.
 DexCom, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes continuous glucose monitoring systems for management of diabetes & metabolic health by patients, caregivers and clinicians | Health Technology |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices for diabetes disease | Health Technology |
